COLLEGIUM PHARMACEUTICAL INC (COLL) Fundamental Analysis & Valuation

NASDAQ:COLL • US19459J1043

Current stock price

34.895 USD
-0.82 (-2.31%)
Last:

This COLL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. COLL Profitability Analysis

1.1 Basic Checks

  • COLL had positive earnings in the past year.
  • COLL had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: COLL reported negative net income in multiple years.
  • COLL had a positive operating cash flow in 4 of the past 5 years.
COLL Yearly Net Income VS EBIT VS OCF VS FCFCOLL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • COLL's Return On Assets of 3.64% is amongst the best of the industry. COLL outperforms 84.90% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.27%, COLL belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 9.10%, COLL belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for COLL is in line with the industry average of 12.98%.
Industry RankSector Rank
ROA 3.64%
ROE 21.27%
ROIC 9.1%
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
COLL Yearly ROA, ROE, ROICCOLL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • COLL has a better Profit Margin (7.72%) than 83.85% of its industry peers.
  • COLL's Profit Margin has declined in the last couple of years.
  • COLL has a Operating Margin of 20.74%. This is amongst the best in the industry. COLL outperforms 88.02% of its industry peers.
  • In the last couple of years the Operating Margin of COLL has grown nicely.
  • COLL's Gross Margin of 57.22% is fine compared to the rest of the industry. COLL outperforms 68.75% of its industry peers.
  • COLL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.74%
PM (TTM) 7.72%
GM 57.22%
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
COLL Yearly Profit, Operating, Gross MarginsCOLL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. COLL Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
  • There is no outstanding debt for COLL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COLL Yearly Shares OutstandingCOLL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
COLL Yearly Total Debt VS Total AssetsCOLL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that COLL is in the distress zone and has some risk of bankruptcy.
  • COLL has a Altman-Z score of 1.32. This is comparable to the rest of the industry: COLL outperforms 58.33% of its industry peers.
  • COLL has a debt to FCF ratio of 2.79. This is a good value and a sign of high solvency as COLL would need 2.79 years to pay back of all of its debts.
  • The Debt to FCF ratio of COLL (2.79) is better than 91.15% of its industry peers.
  • A Debt/Equity ratio of 2.71 is on the high side and indicates that COLL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.71, COLL is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 2.79
Altman-Z 1.32
ROIC/WACC0.99
WACC9.2%
COLL Yearly LT Debt VS Equity VS FCFCOLL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that COLL should not have too much problems paying its short term obligations.
  • COLL has a worse Current ratio (1.36) than 74.48% of its industry peers.
  • COLL has a Quick Ratio of 1.27. This is a normal value and indicates that COLL is financially healthy and should not expect problems in meeting its short term obligations.
  • COLL has a Quick ratio of 1.27. This is in the lower half of the industry: COLL underperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.27
COLL Yearly Current Assets VS Current LiabilitesCOLL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. COLL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.66% over the past year.
  • COLL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.90% yearly.
EPS 1Y (TTM)15.66%
EPS 3Y137.06%
EPS 5Y57.9%
EPS Q2Q%15.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.92%

3.2 Future

  • COLL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.39% yearly.
  • Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 1.28% on average per year.
EPS Next Y2.08%
EPS Next 2Y-5.87%
EPS Next 3Y-12.23%
EPS Next 5Y-2.39%
Revenue Next Year3.9%
Revenue Next 2Y-2.3%
Revenue Next 3Y-2.41%
Revenue Next 5Y1.28%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
COLL Yearly Revenue VS EstimatesCOLL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
COLL Yearly EPS VS EstimatesCOLL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. COLL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.68 indicates a rather cheap valuation of COLL.
  • Based on the Price/Earnings ratio, COLL is valued cheaply inside the industry as 96.35% of the companies are valued more expensively.
  • COLL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.11.
  • With a Price/Forward Earnings ratio of 4.58, the valuation of COLL can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, COLL is valued cheaply inside the industry as 95.83% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.12. COLL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.68
Fwd PE 4.58
COLL Price Earnings VS Forward Price EarningsCOLL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, COLL is valued cheaper than 97.40% of the companies in the same industry.
  • 97.40% of the companies in the same industry are more expensive than COLL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.83
EV/EBITDA 3.97
COLL Per share dataCOLL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COLL does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of COLL may justify a higher PE ratio.
  • COLL's earnings are expected to decrease with -12.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)2.24
PEG (5Y)0.08
EPS Next 2Y-5.87%
EPS Next 3Y-12.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. COLL Dividend Analysis

5.1 Amount

  • No dividends for COLL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

COLL Fundamentals: All Metrics, Ratios and Statistics

COLLEGIUM PHARMACEUTICAL INC

NASDAQ:COLL (3/18/2026, 12:34:45 PM)

34.895

-0.82 (-2.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners122.15%
Inst Owner Change1.07%
Ins Owners2%
Ins Owner Change1.41%
Market Cap1.11B
Revenue(TTM)N/A
Net Income(TTM)58.44M
Analysts81.67
Price Target54.74 (56.87%)
Short Float %14.85%
Short Ratio9.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.9%
Min EPS beat(2)1.88%
Max EPS beat(2)7.92%
EPS beat(4)4
Avg EPS beat(4)6.15%
Min EPS beat(4)1.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)-15.06%
EPS beat(16)10
Avg EPS beat(16)-21.97%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)1.9%
Max Revenue beat(2)8.53%
Revenue beat(4)3
Avg Revenue beat(4)2.75%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)8.53%
Revenue beat(8)4
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-3.75%
PT rev (1m)0.94%
PT rev (3m)14.67%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-5.95%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-1.1%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-0.35%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 4.68
Fwd PE 4.58
P/S 1.46
P/FCF 3.83
P/OCF 3.81
P/B 4.03
P/tB N/A
EV/EBITDA 3.97
EPS(TTM)7.46
EY21.38%
EPS(NY)7.62
Fwd EY21.82%
FCF(TTM)9.11
FCFY26.11%
OCF(TTM)9.16
OCFY26.26%
SpS23.84
BVpS8.66
TBVpS-18.77
PEG (NY)2.24
PEG (5Y)0.08
Graham Number38.12
Profitability
Industry RankSector Rank
ROA 3.64%
ROE 21.27%
ROCE 13.6%
ROIC 9.1%
ROICexc 12.09%
ROICexgc N/A
OM 20.74%
PM (TTM) 7.72%
GM 57.22%
FCFM 38.21%
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF 2.79
Debt/EBITDA 1.94
Cap/Depr 0.72%
Cap/Sales 0.21%
Interest Coverage 2.17
Cash Conversion 75.92%
Profit Quality 495.01%
Current Ratio 1.36
Quick Ratio 1.27
Altman-Z 1.32
F-Score7
WACC9.2%
ROIC/WACC0.99
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.66%
EPS 3Y137.06%
EPS 5Y57.9%
EPS Q2Q%15.25%
EPS Next Y2.08%
EPS Next 2Y-5.87%
EPS Next 3Y-12.23%
EPS Next 5Y-2.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.92%
Revenue Next Year3.9%
Revenue Next 2Y-2.3%
Revenue Next 3Y-2.41%
Revenue Next 5Y1.28%
EBIT growth 1Y-18.86%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year157.33%
EBIT Next 3Y31.88%
EBIT Next 5Y18.85%
FCF growth 1Y8.55%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y8.67%
OCF growth 3Y25.54%
OCF growth 5Y49.12%

COLLEGIUM PHARMACEUTICAL INC / COLL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COLLEGIUM PHARMACEUTICAL INC (COLL) stock?

ChartMill assigns a fundamental rating of 5 / 10 to COLL.


What is the valuation status for COLL stock?

ChartMill assigns a valuation rating of 8 / 10 to COLLEGIUM PHARMACEUTICAL INC (COLL). This can be considered as Undervalued.


What is the profitability of COLL stock?

COLLEGIUM PHARMACEUTICAL INC (COLL) has a profitability rating of 7 / 10.


Can you provide the financial health for COLL stock?

The financial health rating of COLLEGIUM PHARMACEUTICAL INC (COLL) is 4 / 10.